Cargando…
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union
The development of second-entry topical products is hampered by several factors. The excipient composition should be similar to the reference product because excipients may also contribute to efficacy. Conventional pharmacokinetic bioequivalence studies were not considered acceptable because drug co...
Autores principales: | García-Arieta, Alfredo, Gordon, John, Gwaza, Luther, Merino, Virginia, Mangas-Sanjuan, Víctor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961670/ https://www.ncbi.nlm.nih.gov/pubmed/36839924 http://dx.doi.org/10.3390/pharmaceutics15020601 |
Ejemplares similares
-
Influence of Inter- and Intra-Batch Variability on the Sample Size Required for Demonstration of Equivalent Microstructure of Semisolid Dosage Forms
por: Xu, Zhengguo, et al.
Publicado: (2020) -
Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence
por: Mangas-Sanjuán, Víctor, et al.
Publicado: (2019) -
Erratum: Mangas-Sanjuán, V.; et al. Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence. Pharmaceutics 2019, 11, 503
por: Mangas-Sanjuán, Víctor, et al.
Publicado: (2020) -
Current Evidence, Challenges, and Opportunities of Physiologically Based Pharmacokinetic Models of Atorvastatin for Decision Making
por: Reig-López, Javier, et al.
Publicado: (2021) -
Semisolid Dosage
por: Lunter, Dominique Jasmin, et al.
Publicado: (2020)